Semaglutide is an excellent alternative in patients who have failed bariatric surgery, Antoine Avignon, MD, PhD, professor of nutrition at the University of Montpellier and head of the nutrition-diabetes department at the Montpellier University Hospital Center in France, told Healio
Take home message In Phase 3 trials, retatrutide has produced higher weight loss than Wegovy: 28.7% at 68 weeks on the 12 mg dose, compared with 20.7% at 72 weeks on the newer Wegovy 7.2 mg dose, and 14.9% at 68 weeks on the older 2.4 mg dose
What should I do if oral tirzepatide causes persistent nausea
"It's biology." He says GLP-1 drugs are remarkably effective in countering this pattern
One specific image stood out, however: a before-and-after photo on the Willow site that appears identical to one used on another clinics page (Delilah)